<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: Several reports suggest that duodenogastroesophageal reflux may produce <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of this study was to understand better the relationship of pH (&lt; 4 and &gt; 7), duodenogastroesophageal reflux, and fasting <z:chebi fb="0" ids="3098">bile acid</z:chebi> concentrations in producing esophageal damage </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Using a spectrophotometric technique to measure <z:e sem="disease" ids="C0005403" disease_type="Disease or Syndrome" abbrv="">bile reflux</z:e>, four groups were studied: healthy subjects, reflux patients, patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and patients with esophageal symptoms after partial gastrectomy </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Simultaneous 24-hour pH and bile monitoring of distal esophagus found close association between total percent of time pH &lt; 4 and duodenogastroesophageal reflux (r = 0.78; P &lt; 0.001) but a poor relationship (r = -0.06) with total percent of time pH &gt; 7, suggesting that the term alkaline reflux is a misnomer </plain></SENT>
<SENT sid="4" pm="."><plain>Duodenogastroesophageal reflux increased significantly with the severity of reflux disease, being greatest in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and comparable with that in patients with partial gastrectomy </plain></SENT>
<SENT sid="5" pm="."><plain>Fasting <z:chebi fb="0" ids="3098">bile acid</z:chebi> concentrations did not distinguish patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> from those with reflux </plain></SENT>
<SENT sid="6" pm="."><plain>Rather, increased quantity of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> was the single factor most characterizing patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="14" ids="7772">Omeprazole</z:chebi> (20 mg twice daily) normalized <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> parameters (13.8% +/- 1.6% to 0.8% +/- 0.6%) and significantly (P &lt; 0.001) decreased duodenogastroesophageal reflux (32.8% +/- 6.9% to 4.7% +/- 1.7%) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">Acid reflux</z:e> is the primary factor in the development of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="C0005403" disease_type="Disease or Syndrome" abbrv="">Bile reflux</z:e> parallels <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> and, at best, may have a synergistic role </plain></SENT>
<SENT sid="10" pm="."><plain>Aggressive acid suppression with <z:chebi fb="14" ids="7772">omeprazole</z:chebi> markedly decreases both </plain></SENT>
</text></document>